English|NanjingTech|Contact
专题讲座
科研信息
院务公告
学生事务
专题讲座
学术会议
IAM星火大讲堂

当前位置: 网站首页 通知公告 专题讲座 正文
关于新泽西理工学院Xiaoyang Xu博士学术报告的通知
添加时间:2018/07/28 发布: 管理员
二维码

扫描二维码,在手机中查看。


报告题目:Engineering Nanoparticles for Therapeutics Delivery and Pain Management

报告人:Dr Xiaoyang Xu

邀请人:霍峰蔚教授

报告时间:728日(周六)15:30

报告地点:科技创新大楼C501



Abstract


I will describe the invention and development of new applications in bio-imaging and drug delivery based upon novel polymeric nanoparticle constructs. I will talk about PLGA-PEG based polymeric nanoparticles as drug delivery carriers for the treatment of cancer, cardiovascular disease and obesity. In particular, a siRNA and anticancer drug co-delivery approach has been developed for the treatment of multiple drug resistance (MDR) tumor. The combination of chemotherapy with RNAi approaches to suppress the expression of proteins involved in the emergence of drug-resistance represents a promising synergistic strategy to circumvent or reverse acquired chemoresistance. This combination therapeutic approach can sensitize cancer cell to chemotherapeutics and shows superior tumor inhibition compared to the chemotherapeutics administered as a monotherapy. Additionally, a nanoparticle-mediated anti-cancer drug delivery and pain management approach will be presented, which can not only suppress tumor growth, but also prevent or reduce opioid-induced tolerance and hyperalgesia for optimized cancer pain management.


Biography


Dr. Xiaoyang Xu is an assistant professor in the Department of Chemical and Material Engineering at New Jersey Institute of Technology. Before that, he was a joint NIH postdoctoral fellow in the laboratories of Professors Robert Langer at MIT and Omid Farokhzad at Harvard Medical School. He completed his Ph.D. in Material Chemistry at Northwestern University under the supervision of Prof. Chad Mirkin. He received his B.E. in Chemical Engineering from East China University of Science and Technology in China. Dr. Xu’s research focus is the development of novel biomaterials and nanotechnologies for a variety of medical applications including diagnosis, bioimaging, drug delivery, and regenerative medicine. He is also interested in developing synthetic biomaterials and processing techniques to fabricate hydrogels and scaffolds for use in drug delivery and tissue engineering. Dr. Xu has over 12 years of experience in the synthesis, characterization and testing of a range of biomaterials and nanoparticles for medical applications, leading to over 30 peer-reviewed research articles and 10 issued/pending patents. His publications has been cited over 4,400 times. Dr. Xu has received multiple awards includingRuth L. Kirschstein National Research Service Award,AACR Scholar-in-Training Award,Chinese Government Award for Outstanding Chinese Students Study Abroad, and 1000 Plan Professorship for Young Talent.







Copyright © 2017-2019 万博体育bet 先进材料研究院 All rights reserved.

官方微信
地址:南京市新模范马路5号138信箱总共访问:[旧版回顾]
电话: 025-83587982
Baidu